Alembic Pharmaceuticals has announced a board meeting scheduled for Thursday, February 5th, 2026, to review and approve the unaudited financial results for the quarter and nine months ending December 31st, 2025. Following the declaration of the results, the trading window for company securities will reopen 48 hours after results declaration.
Meeting for Financial Review
A meeting of the Board of Directors at Alembic Pharmaceuticals will be held on Thursday, 5th February, 2026. The primary agenda is to consider and approve the unaudited financial results for the period encompassing the quarter and nine months which concluded on 31st December, 2025.
Trading Window Update
In accordance with company guidelines regarding insider trading, the trading window, previously closed from January 1st, 2026, will reopen for designated persons and their immediate relatives. This will occur 48 hours following the official declaration of the aforementioned financial results.
Source: BSE
